IQSM:NYE-Iq Candriam ESG U.S. Mid Cap Equity ETF (USD)

ETF | Others |

Last Closing

USD 30.325

Change

0.00 (0.00)%

Market Cap

USD 0.20B

Volume

200.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE SOJE

-0.18 (-0.89%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

-0.57 (-1.01%)

USD 33.74B
DFAC Dimensional U.S. Core Equity 2..

-0.04 (-0.12%)

USD 28.45B
DTB DTB

-0.12 (-0.62%)

USD 26.58B
JPST JPMorgan Ultra-Short Income ET..

-0.22 (-0.44%)

USD 24.34B
GBTC Grayscale Bitcoin Trust (BTC)

+2.85 (+5.35%)

USD 23.75B
SGOV iShares® 0-3 Month Treasury B..

-0.40 (-0.40%)

USD 22.81B
JEPQ JPMorgan Nasdaq Equity Premium..

-0.29 (-0.52%)

USD 14.61B
AVUV Avantis® U.S. Small Cap Value..

-0.51 (-0.57%)

USD 11.35B
JAAA Janus Detroit Street Trust - J..

-0.26 (-0.51%)

USD 10.62B

ETFs Containing IQSM

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.70% 38% F 45% F
Dividend Return 0.54% 17% F 13% F
Total Return 1.24% 29% F 37% F
Trailing 12 Months  
Capital Gain 7.01% 53% F 56% F
Dividend Return 0.86% 15% F 10% F
Total Return 7.88% 46% F 48% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.00% 77% C+ 57% F
Dividend Return 4.27% 75% C 49% F
Total Return 0.27% 14% F 6% D-
Risk Return Profile  
Volatility (Standard Deviation) 7.04% 59% D- 83% B
Risk Adjusted Return 60.71% 81% B- 82% B
Market Capitalization 0.20B 74% C 33% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.